RetaMaps

California Weight Clinic

California Weight Clinic · 1720 Jefferson Street · Napa, CA 94559

5.0· 20 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

California Weight Clinic is a weight-loss practice based in Napa, California, whose website describes care delivered online to patients throughout the state, with new-patient and returning-patient pages in English and Spanish and a client portal. The site frames the service as medical support completely online rather than in-office visits, and the listing also includes hormone care. On Google it has a 5.0-star rating across 20 reviews dating back to 2016, 1 in the past year, with reviewers mentioning the staff and the team's knowledge.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 20 reviews
1
reviews in the past year (avg ★ 5.0)

Counts computed by RetaMaps from public Google reviews; most recent review 2025-11-29. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 20 Google reviews. Of the 20 reviews we analyzed, 20 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).

5★
20
4★
0
3★
0
2★
0
1★
0

Most recent Google reviews

Erica T.★★★★★2025-11-29

Love this place…been on the client list for years 💖

Connie N.★★★★★2025-09-19

Always courteous, helpful & fast. Online consultations. Quick shipment of meds. Will refill 2 mo. @ a time. The staff is ALWAYS friendly!

Elise A.★★★★★2025-05-13

I have been going there a long time. Great people

Rosa C.★★★★★2025-05-05

Excellent. They are very nice here.

Suraj K.★★★★★2024-08-12

Good 👍

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs